Late life psychotic features in prodromal Parkinson's disease.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
05 2021
Historique:
received: 06 09 2020
revised: 17 11 2020
accepted: 02 04 2021
pubmed: 19 4 2021
medline: 27 1 2022
entrez: 18 4 2021
Statut: ppublish

Résumé

Some case series have suggested that psychotic features could occur even before the onset of motor symptoms of Parkinson's Disease (PD). Our aim was to investigate a possible association between psychotic symptoms and prodromal Parkinson's disease in a population-based cohort, the Hellenic Longitudinal Investigation of Aging and Diet study. This cross-sectional study included participants aged ≥65 years without dementia or PD. We defined psychotic symptoms as the presence of at least one new hallucinatory or delusional feature, assessed with the Neuropsychiatric Inventory scale and the Columbia University Scale for Psychopathology in Alzheimer's Disease, exhibited only at follow-up and not present at baseline visit. We calculated the probability of prodromal PD (pPD) for every participant, according to the 2019 International Parkinson and Movement Disorders Society research criteria for prodromal PD. Participants who developed psychotic manifestations over a three-year follow up (20 of 914) had 1.3 times higher probability of pPD score (β [95%CI]: 1.3 [0.9-1.5], p=0.006) compared to non-psychotic subjects. This association was driven mostly by depressive symptoms, constipation and subthreshold parkinsonism (p<0.05). Our data indicate that emerging psychotic features evolve in parallel with the probability of pPD. This is the first study that provides evidence for the presence of psychotic experiences in pPD. The association detected needs to be confirmed in longitudinal studies.

Identifiants

pubmed: 33866230
pii: S1353-8020(21)00126-7
doi: 10.1016/j.parkreldis.2021.04.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-73

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Ioanna Pachi (I)

1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Maria I Maraki (MI)

Department of Nutrition and Dietetics, Harokopio University, Athens, Greece; Section of Sport Medicine and Biology of Exercise, School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos Giagkou (N)

1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; Parkinson's Disease and Movement Disorders Department, Hygeia Hospital, Athens, Greece.

Mary H Kosmidis (MH)

Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Mary Yannakoulia (M)

Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.

Efthimios Dardiotis (E)

School of Medicine, University of Thessaly, Larissa, Greece.

Georgios Hadjigeorgiou (G)

Medical School, University of Cyprus, Nicosia, Cyprus.

Paraskevi Sakka (P)

Athens Association of Alzheimer's Disease and Related Disorders, Marousi, Greece.

Eva Ntanasi (E)

1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.

Georgia Xiromerisiou (G)

School of Medicine, University of Thessaly, Larissa, Greece.

Maria Stamelou (M)

1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; Parkinson's Disease and Movement Disorders Department, Hygeia Hospital, Athens, Greece; Medical School, University of Cyprus, Nicosia, Cyprus.

Nikolaos Scarmeas (N)

1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; Taub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.

Leonidas Stefanis (L)

1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. Electronic address: lstefanis@bioacademy.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH